We serve Chemical Name:ethyl benzoate,iodozinc(1+) CAS:282727-18-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl benzoate,iodozinc(1+)
CAS.NO:282727-18-8
Synonyms:3-(Ethoxycarbonyl)phenylzinc iodide solution;3-Ethoxycarbonylphenylzinc iodide 0.5 M in Tetrahydrofuran;MFCD00671981
Molecular Formula:C9H9IO2Zn
Molecular Weight:341.45100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.30000
Exact Mass:339.89400
LogP:2.54670
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2056 3/PG 2
Packing Group:
Contact us for information like 3-(Ethoxycarbonyl)phenylzinc iodide solution chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00671981 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Ethoxycarbonylphenylzinc iodide 0.5 M in Tetrahydrofuran Use and application,3-Ethoxycarbonylphenylzinc iodide 0.5 M in Tetrahydrofuran technical grade,usp/ep/jp grade.
Related News: At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. ethyl benzoate,iodozinc(1+) manufacturer Some of Amanpour’s counterparts also offered well-wishes on Monday. ethyl benzoate,iodozinc(1+) supplier Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. ethyl benzoate,iodozinc(1+) vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. ethyl benzoate,iodozinc(1+) factory The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease.
